McKesson Corp
MCK
ISIN US58155Q1031 / Valor 991041
McKesson Corp
UMushroom community rating:
About company
McKesson Corp is a global healthcare company that provides distribution and services to wholesale, institutional, and retail customers in Europe, Canada, and the United States. The company owns, partners, or franchises with retail pharmacies in Europe and Canada, delivering vital medicines, supplies, and information technology solutions. In the U.S., McKesson's Pharmaceutical segment distributes a wide range of pharmaceutical drugs and healthcare-related products, while also offering practice management, technology, clinical support, and business solutions to various healthcare providers. The company's Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. Additionally, McKesson's Prescription Technology Solutions segment focuses on solving medication access, affordability, and adherence challenges for patients by connecting various stakeholders in the healthcare industry.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (20.08.2024):
Revenue Growth
McKesson Corp reported consolidated revenues of $79.3 billion for the first quarter of fiscal 2025, marking a 6% increase from the same period in the previous year. This growth was primarily driven by increased prescription volumes, including higher volumes from specialty products, retail national account customers, and GLP-1 medications.
Earnings Per Share
For the first quarter of fiscal 2025, McKesson Corp's earnings per diluted share were $7.00, a slight decrease of $0.02 compared to $7.02 in the first quarter of fiscal 2024. However, the adjusted earnings per diluted share saw an 8% increase, rising to $7.88 from $7.27 in the previous year.
Dividend Increase
McKesson Corp's Board of Directors approved a 15% increase to the quarterly dividend, raising it to $0.71 per share. This marks the eighth consecutive year of dividend increases, reflecting the company's strong performance and financial position.
Share Repurchase Program
The Board of Directors also approved a $4.0 billion increase to McKesson Corp's share repurchase program, bringing the total share repurchase authorization to $9.9 billion as of July 2024. This move underscores the company's commitment to returning value to shareholders.
Fiscal 2025 Outlook
McKesson Corp has raised its guidance range for fiscal 2025 adjusted earnings per diluted share to $31.75 to $32.55, up from the previous range of $31.25 to $32.05. This new guidance indicates a projected growth of 16% to 19% compared to the prior year, showcasing the company's confidence in its future performance.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
66345 M
Market cap (USD)
208,173
Daily traded volume (Shares)
521 / 510.42
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
